Back to Authors

Cooper, Gregory S.

https://orcid.org/0000-0002-1019-4326

Mayo Clinic

Cleveland Clinic

Citations 4

NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024
Llor, Xavier , Abbass, Mohammad Ali , Chen, Christopher T. , Cooper, Gregory S. , Early, Dayna S., Friedman, Mark , Fudman, David , Giardiello, Francis M., Glaser, Kathryn , Gurudu, S, Hall, Michael J. , Issaka, Rachel B. , Kidambi, Trilokesh D. , Lazenby, Audrey J., Maratt, Jennifer K. , Markowitz, Arnold J. , Marsano, Joseph, Olortegui, Kinga Skowron , Peter, Shajan , Porter, Laura , Shafi, Mehnaz, Terdiman, Jonathan P., Vu, Peter , Wood, Elizabeth H., Cassara, Carly J., Gurudu, Surya, Ness, Reid M. , Bishu, Shrinivas , Huang, Lyen C. , Katona, Bryson W , May, Folasade P. , Mayer, Robert J. , Olortegui, Kinga S. , Patel, Swati , Stanich, Peter P. , Weiss, Jennifer M. , Wood, Elizabeth, Sambandam, Vaishnavi

Journal of the National Comprehensive Cancer Network | September 5, 2024 | Volume: 22 | Issue: 7 | Pages: 438-446

10.6004/jnccn.2024.0047 Get It

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel’s recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.
S875 Atovaquone and Proguanil vs Hepatitis A Vaccine, Hydroxychloroquine, and Mesalamine in Patients With IBD: A Propensity Score Matched Cohort Comparison of Strategically Selected Comparators
Nadeem, Ahmed, Pérez, Jaime A. , Dulai, Parambir S. , Sandborn, William J. , David, Aidan J., Cooper, Gregory S. , Leighton, Jonathan A. , David, Joseph , Hanauer, Stephen B. , Regueiro, Miguel , Mansoor, Emad

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S651-S651

10.14309/01.ajg.0000953140.01023.e0 Get It

S874 Impact of Atovaquone and Proguanil on Steroid Use, Hospitalization, and Advanced Therapeutic Use in Patients With IBD: A Propensity Matched Cohort Study
Nadeem, Ahmed, Pérez, Jaime A. , Dulai, Parambir S. , Sandborn, William J. , David, Aidan J., Cooper, Gregory S. , Leighton, Jonathan A. , David, Joseph , Hanauer, Stephen B. , Regueiro, Miguel , Mansoor, Emad

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S650-S650

10.14309/01.ajg.0000953136.72575.4f Get It

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020
Provenzale, Dawn, Llor, Xavier , Abbadessa, Benjamin, Cooper, Gregory S. , Early, Dayna S., Friedman, Mark , Giardiello, Francis M., Glaser, Kathryn , Gurudu, Suryakanth, Halverson, Amy L. , Issaka, Rachel B. , Jain, Rishi , Kidambi, Trilokesh D. , Lazenby, Audrey J., Markowitz, Arnold J. , May, Folasade P. , Mehta, Shivan J. , Peter, Shajan , Stanich, Peter P. , Terdiman, Jonathan P., Keller, Jennifer , Dwyer, Mary A., Ogba, Ndiya , Ness, Reid M. , Weiss, Jennifer M. , Kanth, Priyanka , Maguire, Lillias Holmes , Mayer, Robert J. , Patel, Swati

Journal of the National Comprehensive Cancer Network | October 6, 2020 | Volume: 18 | Issue: 10 | Pages: 1312-1320

10.6004/jnccn.2020.0048 Get It

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel’s recommendations regarding the age to initiate screening in average risk individuals and follow-up for low-risk adenomas.